Invention Grant
- Patent Title: Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
-
Application No.: US16541033Application Date: 2019-08-14
-
Publication No.: US10919879B2Publication Date: 2021-02-16
- Inventor: Srinivasa Rao Akireddy , Balwinder Singh Bhatti , Timothy J. Cuthbertson , Gary Maurice Dull , Craig Harrison Miller , Joseph Pike Mitchener, Jr. , Julio A. Munoz , Pieter Albert Otten
- Applicant: Oyster Point Pharma, Inc.
- Applicant Address: US NJ Princeton
- Assignee: Oyster Point Pharma, Inc.
- Current Assignee: Oyster Point Pharma, Inc.
- Current Assignee Address: US NJ Princeton
- Agency: Cooley LLP
- Main IPC: C07D403/06
- IPC: C07D403/06 ; C07C59/255 ; A61K31/4025 ; C07C59/265
Abstract:
The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.
Public/Granted literature
- US20200207740A1 SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE Public/Granted day:2020-07-02
Information query
